Vitamin E: Protective role of a Janus molecule

FASEB Journal

Volumn 15, Issue 13, 2001, Pages 2314-2325

  Ricciarelli, Roberta ^a   Zingg, Jean Marc ^a   Azzi, Angelo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antioxidant; Atherosclerosis; Intervention trials; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; BINDING PROTEIN; ESTRADIOL; FREE RADICAL; JANUS KINASE; PROTEIN KINASE C; RETINAL; RHODOPSIN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CELL PROLIFERATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; FRIEDREICH ATAXIA; GENE EXPRESSION REGULATION; HUMAN; ISCHEMIC HEART DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VITAMIN DEFICIENCY; VITAMIN METABOLISM;

EID: 0035159165     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0258rev     Document Type: Review

References (121)

1. Fetal resorption
2. Tocopherols in foods
3. Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle
4. Distribution of alpha-tocopherol in human plasma lipoproteins
5. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells
6. HDL is the major source of vitamin E for type II pneumocytes
7. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E
8. High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles
9. Carotenoids and fat-soluble vitamins: Contribution to food, feed and pharmaceuticals
10. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs
11. Preferential incorporation of alpha-tocopherol vs. gamma-tocopherol in human lipoproteins
12. Vitamin E: Function and metabolism
13. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders
14. Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene
15. Alpha-tocopherol transfer protein gene: Exon skipping of all transcripts causes ataxia
16. Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice
17. A novel human tocopherol-associated protein: Cloning, in vitro expression, and characterization
18. Identification of a low molecular mass (14.2 kDa) alpha-tocopherol-binding protein in the cytosol of rat liver and heart
19. Molecular mechanism of cellular uptake and intracellular translocation of alpha-tocopherol: Role of tocopherol-binding proteins
20. Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping
21. Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene
22. Correlation of repressed transcription of alpha-tocopherol transfer protein with serum alpha-tocopherol during hepatocarcinogenesis
23. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
24. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism
25. Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein
26. Ataxia with isolated vitamin E deficiency: Heterogeneity of mutations and phenotypic variability in a large number of families
27. Dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells
28. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
29. Vitamin E and vascular homeostasis: Implications for atherosclerosis
30. Friedreich's ataxia and hereditary vitamin E deficiency. Case study
31. Vitamin E deficiency ataxia associated with adenoma
32. Antioxidant protection of LDL by physiological concentrations of 17 beta-estradiol. Requirement for estradiol modification
33. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
34. Antioxidant reactions of all-trans retinol in phospholipid bilayers: Effect of oxygen partial pressure, radical fluxes, and retinol concentration
35. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling
36. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis
37. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins
38. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium
39. Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein
40. Vitamin E in human low-tensity lipoprotein. When and how this antioxidant becomes a pro-oxidant
41. Tocopherol-mediated peroxidation of lipoproteins: Implications for vitamin E as a potential antiatherogenic supplement
42. The ambivalence of vitamin E in atherogenesis
43. Gamma-tocopherol: An efficient protector of lipids against nitric oxide-initiated peroxidative damage
44. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: Physiological implications
45. The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite
46. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C
47. D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties
48. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
49. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism
50. Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations
51. Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells
52. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation
53. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase
54. The antioxidant hypothesis of cardiovascular disease: Epidemiology and mechanisms
55. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants
56. Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state
57. The effect of alpha-tocopherol on the synthesis, phosphorylation and activin, of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation
58. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: Molecular pathways and structural requirements
59. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol
60. RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status
61. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells
62. Long- and short-term D-alpha-tocopherol supplementation inhibits liver collagen alphal (I) gene expression
63. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition
64. Liver alpha-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats
65. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages
66. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells
67. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages
68. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
69. Alpha-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells
70. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro
71. Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells
72. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes
73. Alpha-tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells
74. Dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells
75. Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia
76. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis
77. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation
78. Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque - Effect of vitamin E supplementation
79. D-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity
80. The effect of alpha-tocopherol on monocyte proatherogenic activity
81. Vitamin E and macrophage cyclooxygenase regulation in the aged
82. Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E
83. Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits
84. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits
85. Low-dose alpha-tocopherol improves and high-dose alphatocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits
86. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E
87. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis
88. Vitamin E and heart disease: Basic science to clinical intervention trials
89. Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice
90. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
91. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero) xides in Watanabe heritable hyperlipidemic rabbits
92. Vitamin E and other essential antioxidants regarding coronary heart disease: Risk assessment studies
93. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels
94. Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study
95. Vitamin E consumption and the risk of coronary disease in women
96. Antioxidants and coronary heart disease: Observational studies
97. Vitamin E consumption and the risk of coronary heart disease in men
98. Carotid intima-media thickness as a surrogate end point for coronary, artery disease
99. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images
100. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA study. Etude sur le vieillisement arteriel
101. Ultrasound B-mode imaging in observational studies of atherosclerotic progression
102. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
103. The Cholesterol Lowering Atherosclerosis Study (CLAS): Design, methods, and baseline results
104. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
105. Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)
106. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
107. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
108. Do vitamin E and fish oil protect against ischaemic heart disease?
109. GISSI-Prevenzione trial
110. GISSI-Prevenzione trial
111. GISSI-Prevenzione trial
112. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
113. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance
114. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-tocopherol
115. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
116. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease
117. Vitamin E supplementation and cardiovascular events in high-risk patients
118. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
119. The antioxidant paradox
120. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults
121. Apolipoprotein E polymorphism and atherosclerosis: Association of the epsilon4 allele with defects in the internal elastic lamina